These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7646183)

  • 21. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
    Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ
    Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset and progression of experimental bioprosthetic heart valve calcification.
    Schoen FJ; Levy RJ; Nelson AC; Bernhard WF; Nashef A; Hawley M
    Lab Invest; 1985 May; 52(5):523-32. PubMed ID: 3990244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
    Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
    Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
    Neethling WM; Hodge AJ; Clode P; Glancy R
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model.
    Flameng W; Hermans H; Verbeken E; Meuris B
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):340-5. PubMed ID: 25439467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the tricuspid position suitable for testing replacement bioprosthetic valves in the sheep model?
    Pettenazzo E; Thiene G; Gatti AM; Pasquino E; Talenti E; Noera G; Bottio T; Valente M
    J Heart Valve Dis; 2001 Jul; 10(4):513-9. PubMed ID: 11499599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No-react detoxification process: a superior anticalcification method for bioprostheses.
    Abolhoda A; Yu S; Oyarzun JR; Allen KR; McCormick JR; Han S; Kemp FW; Bogden JD; Lu Q; Gabbay S
    Ann Thorac Surg; 1996 Dec; 62(6):1724-30. PubMed ID: 8957377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of failure modes of glutaraldehyde-treated versus antibiotic-preserved mitral valve allografts implanted in sheep.
    Tamura K; Jones M; Yamada I; Ferrans VJ
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):224-38. PubMed ID: 7609546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo.
    Xi T; Ma J; Tian W; Lei X; Long S; Xi B
    J Biomed Mater Res; 1992 Sep; 26(9):1241-51. PubMed ID: 1429769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model.
    Webb CL; Schoen FJ; Levy RJ
    ASAIO Trans; 1988; 34(3):855-9. PubMed ID: 3143392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep.
    Schoen FJ; Hirsch D; Bianco RW; Levy RJ
    J Thorac Cardiovasc Surg; 1994 Nov; 108(5):880-7. PubMed ID: 7967670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships.
    Vyavahare NR; Hirsch D; Lerner E; Baskin JZ; Zand R; Schoen FJ; Levy RJ
    J Biomed Mater Res; 1998 Jun; 40(4):577-85. PubMed ID: 9599034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
    De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
    J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-glutamic acid in the prevention of the calcification of bovine pericardial fixed in glutaraldehyde: study in rats.
    Ferreira AD; Costa FD; Santos EA; Sardeto EA; Gomes CH; Collatusso C; Lopes SA; Perruzzo A; Costa Ide S
    Rev Bras Cir Cardiovasc; 2007; 22(3):303-9. PubMed ID: 18157416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of delay between tissue harvest and glutaraldehyde pretreatment on mineralization of bovine pericardium used in bioprosthetic heart valves.
    Maranto AR; Schoen FJ
    J Biomed Mater Res; 1988 Sep; 22(9):819-25. PubMed ID: 3146571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing calcification of cardiac bioprostheses in adolescent sheep.
    Flameng W; Meuris B; Yperman J; De Visscher G; Herijgers P; Verbeken E
    J Thorac Cardiovasc Surg; 2006 Jul; 132(1):89-98. PubMed ID: 16798307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
    Chen W; Kim JD; Schoen FJ; Levy RJ
    J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term anticalcification effect of Fe3+ in rat subdermal implants of glutaraldehyde preserved bovine pericardium.
    Baldwin MT; Ciesliga BL; Barkasi LD; Webb CL
    ASAIO Trans; 1991; 37(3):M170-2. PubMed ID: 1751096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
    Weissenstein C; Human P; Bezuidenhout D; Zilla P
    J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.
    Levy RJ; Schoen FJ; Lund SA; Smith MS
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.